Durvalumab with first-line chemotherapy in previously...

The Lancet Oncology 2020 / 09 Vol. 21; Iss. 9

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

Nowak, Anna K, Lesterhuis, W Joost, Kok, Peey-Sei, Brown, Chris, Hughes, Brett GM, Karikios, Deme J, John, Thomas, Kao, Steven C-H, Leslie, Connull, Cook, Alistair M, Pavlakis, Nick, Briscoe, Karen, O
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30462-9
Date:
September, 2020
File:
PDF, 65 KB
2020
Conversion to is in progress
Conversion to is failed